Medtech startup Endomedix is feeling the excitement and satisfaction that follows five years of hard work, and the company is poised for its next key stage of growth. Led by CEO Richard Russo, a veteran at developing products and building businesses, Endomedix has overcome many of the challenges and early missteps that overwhelm most medical device startups.
Russo came to Endomedix in 2009 after the firm’s initial progress had stalled. He immediately identified core problems and addressed them head-on. This included changing the firm’s business model and the direction of its product development program which eliminated most of the product concepts under development. While building a platform technology, Russo directed Endomedix towards commercializing its first product, a gel spray that controls bleeding during surgery…